Genegut
GENEGUT is a Horizon Europe project (GA No. 101057491), developing a first-in-class oral RNA-based therapy to treat ileal Crohn's Disease. Coordinated by the University College Cork School of Pharmacy and APC Microbiome Ireland. Through a patient-centred approach and grown out of the recent Cost Action UNGAP (CA16205), GENEGUT brings together a patient association with renowned researchers, expert clinical scientists, SMEs and large pharma companies with expertise and patented technologies in global proteomics, nanotechnologies, cyclodextrin synthesis, multicellular models, drug delivery systems and production as well as innovation management, stakeholder involvement and science communication. Page reflects only the views of GENEGUT.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
2
11 to 50 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Genegut
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Genegut
1 distinct titles indexed · top 1 shown.
- 1research phd candidate
Sign up to unlock all 2 contacts at Genegut
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Genegut
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.